Articles

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Laboratoire de Biologie et Pharmacologie Appliquee, CNRS UMR 8113, Ecole Normale Superieure de Cachan, France
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Department of Hematology and Oncology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University, Germany
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Department of Laboratory Medicine, Medical University of Vienna, Austria
Department of Laboratory Medicine, Medical University of Vienna, Austria
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria;Department for Companion Animals and Horses, University Clinic for Small Animals, Internal Medicine Small Animals, University of Veterinary Medicine Vienna, Austria
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Elisabethinen Hospital Linz, Austria
Fifth Medical Department, Hospital Hietzing, Vienna, Austria
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Department of Hematology and Oncology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University, Germany
Laboratoire de Biologie et Pharmacologie Appliquee, CNRS UMR 8113, Ecole Normale Superieure de Cachan, France
Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Vol. 103 No. 5 (2018): May, 2018 https://doi.org/10.3324/haematol.2017.179895